UK govt opts not to vaccinate most under-18s against Covid-19 infection

The British government decided on Monday not to inoculate most children and teenagers against COVID-19 until more data on the available vaccines becomes available.

UK govt opts not to vaccinate most under-18s against Covid-19 infection
AP London
2 min read Last Updated : Jul 19 2021 | 10:34 PM IST

The British government decided on Monday not to inoculate most children and teenagers against COVID-19 until more data on the available vaccines becomes available.

Children as young as 12 with severe neuro-disabilities, Down Syndrome, immunosuppression and multiple or severe learning disabilities, as well as those who are household contacts of individuals who are immunosuppressed, will be eligible for vaccination, the government said.

The decision to hold off giving shots to most people under age 18 was based on the recommendation of an expert advisory panel. The Joint Committee on Vaccination and Immunisation said the health benefits of universal vaccination don't outweigh the risks for most young people, who typically suffer only mild symptoms of the virus.

"Today's advice does not recommend vaccinating under-18s without underlying health conditions at this point in time, Health Secretary Sajid Javid said in a statement. But the JCVI will continue to review new data, and consider whether to recommend vaccinating under-18s without underlying health conditions at a future date.''

The move puts the UK at odds with France and several other European countries, which have decided to vaccinate adolescents as young as 12.

Among hundreds of people at a Paris vaccination center Friday, scores were teenagers with their parents. The French government announced last week that it plans to set up vaccine drives at middle schools, high schools and universities in the fall.

Children and teenagers who are eligible in the UK will receive the Pfizer-BioNTech vaccine, the only one the country has authorized for use in that age group.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusUK govtCoronavirus VaccineVaccination

First Published: Jul 19 2021 | 10:34 PM IST

Next Story